Ras Related Oncogene Protein as a Tumor Marker in Transitional Cell Carcinoma of the Bladder

Publisher Website
Google Scholar
Abstract
An oncogene related protein has been detected in the urine of patients with transitional cell carcinoma (TCC). This is a 55 kilodalton protein (p55) which is immunologically related to the ras oncogene product p21. Sixteen patients with TCC (55%) and none of the controls exhibited hight level of p55 expression (greater than or equal to 3 .times. the level of background). There were ten cancer patients (35%) who had 2 .times. the level of background and three patients (10%) who had the level of background. In contrast, there were two non-cancer patients with 2 .times. level of expression (9%) and the remainder (91%) had the background level of p55 expression. The expression of the marker (p55) tends to correlate with tumor grade and stage and is elevated in patients with a history of multiple recurrences. The ras oncogene has been identified in the tissues of a wide variety of cancers and is not a marker which is specific for any single cancer. The identification of its related gene product in the urine may be useful as a marker for TCC.